查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1987966

剂量监测设备市场：按类型、技术、应用、最终用户和分销管道划分－2026-2032年全球市场预测

Dose Monitoring Device Market by Type, Technology, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，剂量监测设备市场价值将达到 39.3 亿美元，到 2026 年将成长至 42.8 亿美元，到 2032 年将达到 73.2 亿美元，复合年增长率为 9.29%。

主要市场统计数据
基准年 2025 39.3亿美元
预计年份：2026年 42.8亿美元
预测年份 2032 73.2亿美元
复合年增长率 (%) 9.29%

这是一本针对医疗保健决策者的剂量监测设备重要指南，系统地说明了其临床意义、技术前景和策略考量。

剂量监测设备是临床安全、数位医疗创新和个人化患者照护的关键所在。这些系统种类繁多，从整合到临床工作流程中的简单、非穿戴式剂量追踪器，到能够持续记录给药事件并透过无线通讯协定传输资料的先进穿戴式平台，应有尽有。随着医疗保健系统将药物依从性、减少可预防的不利事件和远端病患管理置于优先地位，剂量监测设备正从小众工具发展成为实现互联互通的医疗路径的关键基础。

感测器技术的创新、对互通性的需求以及护理模式的转变，都在共同作用，促使人们重新思考药物监测设备的产品设计和市场进入策略。

药物监测设备的市场格局正在经历一场变革，这场变革是由技术、临床和营运等多面向因素共同推动的。感测器小型化和低功耗无线通讯技术的进步，使得穿戴式装置得以开发，从而能够隐密地追踪用药情况。同时，物联网基础设施的改进，也促进了近乎即时的资料流向医疗管理平台。这些技术基础正在降低使用门槛，并提高患者持续参与的可能性。

2025 年关税变化和贸易结构调整将如何对药物监测设备整个价值链的策略采购、在地化选择和韧性规划构成挑战？

2025年计画进行的关税和贸易政策调整将为整个药物监测设备生态系统的供应链和采购决策带来更多战略层面的影响。传统上依赖跨境零件采购和契约製造的製造商需要重新评估供应商多元化、库存策略以及潜在的在岸和近岸生产机会，以降低成本波动并维持供应的连续性。这些变更可能会影响前置作业时间、零件选择和供应商认证流程。

以细分市场为中心的洞察揭示了类型、应用、技术、最终用户环境和分销选项如何决定部署路径和产品优先顺序。

为了解产品和市场动态，必须清楚掌握设备按外形规格、临床应用、底层技术、终端用户环境和通路进行分类的方式。按类型划分，市场分为非穿戴式装置和穿戴式装置两大类，每类设备都体现了不同的设计限制和应用情境。非穿戴式系统优先考虑与临床基础设施的整合和稳定性，而穿戴式解决方案则强调舒适性、电池效率和持续性资料收集。按应用划分，市场涵盖心血管护理、糖尿病管理和肿瘤学领域。每个应用领域都有其独特的临床工作流程、用药依从性挑战和监管要求，这些都会影响感测器选择和资料模型。

医疗保健系统、法规和基础设施的区域差异如何影响剂量监测解决方案的部署策略和营运重点？

区域趋势受关键区域医疗保健系统结构、法律规范和部署模式差异的影响。美洲的医疗保健格局复杂，其特点是整合的医疗保健系统、以支付主导的价值评估，以及对远端患者监护解决方案的强劲需求，以支持慢性病管理。在该地区运作的相关人员必须使临床证据和报销策略与不同相关人员的期望和支付系统相协调。欧洲、中东和非洲（EMEA）地区则呈现出监管严格和各国市场基础设施​​成熟度不一的局面。虽然互通性和资料保护是成熟的欧洲医疗保健系统的首要关注点，但中东和非洲的一些市场则优先考虑扩充性、经济高效的解决方案和伙伴关係关係，以加速在资源受限环境中的部署。

医疗设备製造商与技术供应商之间的企业策略、合作关係和服务创新正在塑造竞争差异化和伙伴关係的机会。

企业级趋势的特点是产品创新、平台整合、策略伙伴关係以及不断发展的服务交付模式的融合。成熟的医疗设备製造商正利用其在监管方面的专业知识和快速上市管道，将其产品组合扩展到剂量监测领域，通常会整合分析和云端服务，为医疗服务提供者建立捆绑式解决方案。同时，科技主导的新兴参与企业正透过用户体验、快速的产品改进和平台扩充性来脱颖而出，专注于无缝的行动连接和以消费者为中心的设计，以促进居家医疗环境中的用户参与。

为高阶主管提供切实可行的策略措施，以增强韧性、加速推广并在剂量监测设备市场中获得差异化价值。

产业领导者应采取一系列切实可行的措施，以平衡短期韧性与长期差异化。首先，应优先考虑互通性和基于标准的集成，使设备能够连接到各种电子健康记录环境和分析平台。这将减轻医疗专业人员的部署负担，并增强支援长期照护解决方案的吸引力。

采用透明、以证据为基础的调查方法，结合实务工作者访谈、标准审查和技术比较分析，为合理的决策提供支援。

本研究途径整合了来自一手和二手资料的证据，旨在产生可操作的洞见，同时确保透明度和可重复性。主要输入包括对临床医生、采购经理、技术整合商和供应链专家的结构化访谈，并辅以诊所、医院和居家照护机构的案例研究。这些定性观点为工作流程整合、可用性挑战和实施障碍提供了背景资讯——而这些资讯仅靠定量数据可能无法捕捉。

策略挑战的整合，展示了技术、临床证据和营运韧性的整合如何决定剂量监测的长期成功。

剂量监测设备正处于策略转折点，技术能力、临床需求和实际操作性在此交汇融合。其部署的最终结果将取决于製造商和服务供应商能否将感测器和连接方面的创新转化为检验、可互通的解决方案，以适应现有的临床工作流程并支援远距医疗。监管政策的明确、支付方的参与以及临床疗效的证据将推动其应用，而不断变化的收费系统和日益复杂的供应链将考验企业的韧性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 剂量监测设备市场：依类型划分

  • 不可穿戴
  • 穿戴式装置

第九章 剂量监测设备市场：依技术划分

  • Bluetooth
  • 基于物联网
  • NFC
  • RFID

第十章：剂量监测设备市场：依应用领域划分

  • 循环系统护理
  • 糖尿病管理
  • 癌症治疗

第十一章 剂量监测设备市场：依最终用户划分

  • 诊所
  • 居家医疗
  • 医院

第十二章 剂量监测设备市场：依通路划分

  • 离线频道
    • 直销
    • 销售代理
  • 线上管道
    • EC平台
    • 製造商网站

第十三章 剂量监测设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 剂量监测设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 剂量监测设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国剂量监测设备市场

第十七章：中国剂量监测设备市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Bayer AG
  • Bracco SpA
  • Canon Inc.
  • Dozee
  • Fluke Corporation
  • Fuji Electric Co., Ltd.
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies, Inc.
  • Guerbet
  • IBA Dosimetry GmbH
  • Infab Corporation
  • INFINITT Healthcare Co., Ltd.
  • Ion Beam Applications SA
  • Koninklijke Philips NV
  • Landauer, Inc.
  • LANDAUER, Inc. by Fortive Corporation
  • Medic Vision
  • Medsquare
  • Mirion Technologies, Inc.
  • Novarad Corporation
  • PACSHealth, LLC
  • PTW-Freiburg GmbH
  • QAELUM NV
  • Radcal Corporation
  • Radiation Monitoring Devices, Inc.
  • RADOS Technology Oy
  • RaySafe by Fluke Corporation
  • Sectra AB
  • Siemens Healthineers AG
  • Thermo Fisher Scientific, Inc.
  • Unfors RaySafe AB
  • Victoreen, LLC
  • Volpara Health Limited
Product Code: MRR-A413C23B631F

The Dose Monitoring Device Market was valued at USD 3.93 billion in 2025 and is projected to grow to USD 4.28 billion in 2026, with a CAGR of 9.29%, reaching USD 7.32 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.93 billion
Estimated Year [2026] USD 4.28 billion
Forecast Year [2032] USD 7.32 billion
CAGR (%) 9.29%

An essential introduction to dose monitoring devices that frames clinical relevance, technological expectations, and strategic considerations for healthcare decision-makers

Dose monitoring devices sit at the intersection of clinical safety, digital health innovation, and individualized patient care. These systems range from simple non-wearable dose trackers integrated into clinical workflows to advanced wearable platforms that continuously log administration events and transmit data through wireless protocols. As healthcare systems emphasize medication adherence, reduction of preventable adverse events, and remote patient management, dose monitoring devices have evolved from niche tools into critical enablers of coordinated care pathways.

Clinicians and healthcare administrators now expect solutions that not only record dosing events but also integrate seamlessly with electronic health records, support interoperability standards, and enable analytics for population health management. At the same time, consumer-facing expectations are shaping device design: usability, unobtrusiveness, and secure connectivity are central to adoption in homecare settings. Regulatory scrutiny and reimbursement dynamics further drive product development, compelling manufacturers to demonstrate safety, privacy controls, and clinical value in rigorous settings.

Consequently, investment in dose monitoring must balance technical innovation with human-centered design and evidence generation. Decision-makers should consider how devices will function across point-of-care environments, how they will integrate with clinical workflows, and how data governance frameworks will ensure patient privacy and regulatory compliance. The following sections unpack the transformative shifts, tariff-related headwinds, segmentation dynamics, regional behavior, company-level developments, and actionable recommendations that stakeholders should weigh as they design their next moves in this evolving domain.

The confluence of sensor innovation, interoperability demands, and care model transformation reshaping product design and go-to-market strategies for dose monitoring devices

The landscape for dose monitoring devices is undergoing a phase of transformative change driven by converging technological, clinical, and operational forces. Advances in sensor miniaturization and low-power wireless communications have enabled the development of wearables that can unobtrusively track dosing events, while improvements in IoT infrastructure facilitate near-real-time data flows into care management platforms. These technical enablers reduce friction at the point of use and increase the likelihood of sustained patient engagement.

Simultaneously, clinical paradigms are shifting toward value-based care models that prioritize outcomes and adherence metrics. This shift compels providers and payers to view dose monitoring not as an isolated device but as part of an ecosystem that links adherence data to clinical decision support, remote monitoring programs, and quality measurement. As a result, interoperability and standards alignment are emerging as non-negotiable design requirements, prompting manufacturers to invest in secure APIs, standardized data models, and compatibility with major electronic health record systems.

Operationally, distribution and service models are being reimagined. The growing expectation for patient-centric services accelerates demand for home-deployable systems and direct-to-consumer channels, while clinical settings favor robust, validated non-wearable solutions that integrate with existing workflows. In parallel, partnerships between device makers, software platform vendors, and clinical service providers are becoming essential to deliver end-to-end solutions that can demonstrate measurable clinical impact. Taken together, these trends are recalibrating product roadmaps, go-to-market strategies, and investment priorities across the ecosystem.

How tariff changes and trade realignments in 2025 compel strategic sourcing, localization choices, and resilience planning across the dose monitoring device value chain

Tariffs and trade policy adjustments scheduled for 2025 introduce an additional strategic dimension for supply chain and sourcing decisions across the dose monitoring device ecosystem. Manufacturers that have historically relied on cross-border component sourcing and contract manufacturing must reassess supplier diversification, inventory strategies, and potential onshoring or nearshoring opportunities to mitigate cost volatility and maintain continuity of supply. These shifts can influence lead times, component selection, and supplier qualification processes.

Beyond pure cost considerations, tariffs affect strategic choices about where to perform value-added activities such as assembly, final testing, and software localization. Firms may decide to relocate certain manufacturing steps closer to primary end markets to reduce exposure, improve responsiveness to regulatory changes, or take advantage of regional incentives. In doing so, they must weigh the operational implications for quality control, intellectual property protection, and access to skilled labor.

Importers and distributors also face operational implications as duty changes alter landed costs and pricing strategies. To preserve margins and market competitiveness, many organizations will explore contractual hedging, long-term supplier agreements, or adjustments to channel strategies. For stakeholders engaging with global partners, proactive scenario planning and a clear communication plan for customers and clinicians will help preserve trust and reduce the risk of service disruption. Ultimately, tariffs in 2025 are prompting a reassessment of resilience, cost management, and strategic localization across the value chain.

Segment-focused insights illuminating how type, application, technology, end-user environment, and distribution choices dictate adoption pathways and product priorities

Understanding product and market dynamics requires a clear view of how devices are segmented by form factor, clinical use, enabling technologies, end-user settings, and distribution pathways. Based on type, the market is studied across non wearable and wearable devices, reflecting distinct design constraints and use cases; non wearable systems prioritize integration with clinical infrastructure and robustness, while wearable solutions emphasize comfort, battery efficiency, and continuous data capture. Based on application, the market is studied across cardiovascular care, diabetes management, and oncology treatment, each application area presenting unique clinical workflows, adherence challenges, and regulatory requirements that influence sensor choice and data models.

Based on technology, the market is studied across Bluetooth, IoT based architectures, NFC, and RFID, which define connectivity, range, and power profiles that determine deployment scenarios; Bluetooth often underpins consumer wearables and short-range device-to-mobile interactions, IoT based approaches support persistent cloud connectivity for remote monitoring, NFC facilitates close-proximity secure exchanges, and RFID enables passive tracking in many clinical environments. Based on end user, the market is studied across clinics, homecare settings, and hospitals, underscoring distinct operational priorities: clinics often focus on episodic interventions and rapid workflows, homecare emphasizes user experience and remote support, and hospitals demand validated integration with enterprise systems and scalable device management.

Based on distribution channel, the market is studied across offline channels and online channels. The offline channels are further studied across direct sales and distributors, reflecting traditional procurement pathways that emphasize service, installation, and institutional contracting. The online channels are further studied across e-commerce platforms and manufacturer websites, which support faster consumer access, digital marketing, and streamlined replenishment. Taken together, these segmentation lenses reveal how product design, pricing, clinical evidence generation, and go-to-market approaches must be aligned to the specific requirements of each segment to drive adoption and sustainable value.

How geographic differences in healthcare systems, regulation, and infrastructure shape adoption strategies and operational priorities for dose monitoring solutions

Regional dynamics are driven by differing healthcare system architectures, regulatory frameworks, and adoption patterns across major geographies. Americas often present a complex landscape shaped by integrated health systems, payer-driven value assessment, and a strong appetite for remote patient monitoring solutions that support chronic disease management; stakeholders operating in this region must align clinical evidence and reimbursement strategies with heterogeneous stakeholder expectations and payer systems. Europe, Middle East & Africa combine regulatory rigor with variable infrastructure maturity across national markets; in mature European healthcare systems, interoperability and data protection are primary concerns, while certain markets in the Middle East & Africa prioritize scalable, cost-effective solutions and partnerships that can accelerate deployment in resource-constrained settings.

Asia-Pacific exhibits broad heterogeneity, with markets ranging from highly tech-forward ecosystems embracing consumer wearables and mobile-first care delivery to regions prioritizing scalable, low-cost devices for wide population reach. Regional supplier networks and manufacturing ecosystems in Asia-Pacific also play an influential role, offering opportunities for cost-effective component sourcing and rapid iterative development. Across all regions, regulatory alignment, local clinical validation, and culturally appropriate user experience design remain decisive factors in determining uptake. Consequently, successful regional strategies blend global product standards with localized implementation plans that address reimbursement, clinical workflow integration, and end-user training.

Corporate strategies, alliances, and service innovations among device makers and technology providers shaping competitive differentiation and partnership opportunities

Company-level dynamics are characterized by a mix of product innovation, platform integration, strategic partnerships, and evolving service offerings. Established medical device firms are leveraging their regulatory expertise and go-to-market channels to extend portfolios into dose monitoring, often embedding analytics and cloud services to create bundled solutions for providers. At the same time, technology-first entrants are differentiating on user experience, rapid product iteration, and platform extensibility, focusing on seamless mobile integration and consumer-grade design to drive engagement in homecare contexts.

Collaborations between device manufacturers, healthcare IT vendors, and clinical service providers are increasingly common, enabling integrated offerings that bridge device telemetry with care management workflows and analytics. Strategic partnerships also facilitate faster route-to-market through distribution agreements, while co-development arrangements help align clinical validation efforts with practitioner needs. In parallel, service expansions that include training, managed monitoring, and outcome reporting are emerging as competitive differentiators, shifting commercial conversations from product sale to value-based service delivery.

For corporate investors and corporate development teams, potential pathways include targeted acquisitions to secure niche capabilities, licensing arrangements for key connectivity technologies, and multi-stakeholder pilots that validate clinical and operational impact. Firms that prioritize interoperability, data security, and a clear value proposition for providers and payers will be better positioned to capture demand as health systems increasingly prioritize adherence and medication safety initiatives.

Practical strategic moves for executives to strengthen resilience, accelerate adoption, and capture differentiated value in dose monitoring device markets

Industry leaders should adopt a set of pragmatic actions that balance near-term resilience with long-term differentiation. First, prioritize interoperability and standards-based integration to ensure devices can plug into diverse electronic health record environments and analytics platforms; this reduces implementation friction for healthcare customers and enhances the appeal of solutions that support longitudinal care.

Second, diversify sourcing and manufacturing footprints to mitigate tariff exposure and supply chain interruptions, while maintaining rigorous quality controls and clear traceability for critical components. Third, invest in clinical validation and outcomes research that demonstrates measurable improvements in adherence, safety, or workflow efficiency; robust evidence will facilitate payer discussions and institutional procurement. Fourth, design products with contextualized user experiences that reflect the needs of homecare patients and frontline clinicians alike, incorporating user-centered design practices and continuous feedback mechanisms to drive iterative improvements.

Finally, develop flexible commercial models that combine device sales with service-based offerings such as managed monitoring, clinician-facing dashboards, and outcome reporting. Such models align incentives across stakeholders and create recurring revenue pathways. Executives should sequence these moves with clear milestones, ensuring that technology investments, regulatory planning, and partnership negotiations progress in parallel to deliver both resilience and differentiated value.

A transparent, evidence-based research methodology integrating practitioner interviews, standards review, and comparative technology analysis to support sound decision-making

The research approach synthesizes evidence from primary and secondary sources to produce actionable insights while ensuring transparency and reproducibility. Primary inputs include structured interviews with clinicians, procurement leaders, technology integrators, and supply chain experts, supplemented by case studies of deployments across clinics, hospitals, and homecare settings. These qualitative perspectives provide context on workflow integration, usability challenges, and deployment barriers that quantitative data alone cannot capture.

Secondary inputs involve a systematic review of regulatory guidance, standards documentation, technology white papers, and peer-reviewed clinical studies relevant to dose monitoring technologies. Special attention is given to interoperability standards, data protection frameworks, and clinical outcome studies that assess device usability and impact. Comparative analysis techniques are applied to examine technology trade-offs-such as connectivity protocols and power management strategies-and to map product features to end-user requirements. Throughout the process, methodological safeguards, including triangulation of sources and explicit documentation of assumptions, are employed to maintain analytical rigor and to support confident decision-making by stakeholders.

Synthesis of strategic imperatives showing how integration of technology, clinical evidence, and operational resilience will determine long-term success in dose monitoring

Dose monitoring devices sit at a strategic inflection point where technological capability, clinical necessity, and operational pragmatism converge. The trajectory for adoption will be shaped by how well manufacturers and service providers can translate sensor and connectivity innovations into validated, interoperable solutions that fit existing clinical workflows and support remote care. Regulatory clarity, payer alignment, and evidence of clinical impact will serve as accelerants, while tariff shifts and supply chain complexity will test organizational resilience.

Stakeholders that prioritize user-centered design, invest in clinical validation, and cultivate partnerships across the care continuum will be positioned to move beyond point solutions toward integrated offerings that deliver measurable value. Conversely, organizations that omit interoperability, fail to address end-user experience, or neglect regional regulatory nuances may encounter adoption friction. Overall, the most successful players will be those that combine technical excellence with pragmatic implementation strategies, clear value propositions for providers and payers, and adaptable commercial models that reflect the diversity of clinical and homecare settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Dose Monitoring Device Market, by Type

  • 8.1. Non Wearable
  • 8.2. Wearable

9. Dose Monitoring Device Market, by Technology

  • 9.1. Bluetooth
  • 9.2. IoT Based
  • 9.3. Nfc
  • 9.4. Rfid

10. Dose Monitoring Device Market, by Application

  • 10.1. Cardiovascular Care
  • 10.2. Diabetes Management
  • 10.3. Oncology Treatment

11. Dose Monitoring Device Market, by End User

  • 11.1. Clinics
  • 11.2. Homecare Settings
  • 11.3. Hospitals

12. Dose Monitoring Device Market, by Distribution Channel

  • 12.1. Offline Channels
    • 12.1.1. Direct Sales
    • 12.1.2. Distributors
  • 12.2. Online Channels
    • 12.2.1. E Commerce Platforms
    • 12.2.2. Manufacturer Websites

13. Dose Monitoring Device Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Dose Monitoring Device Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Dose Monitoring Device Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Dose Monitoring Device Market

17. China Dose Monitoring Device Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Bayer AG
  • 18.6. Bracco S.p.A.
  • 18.7. Canon Inc.
  • 18.8. Dozee
  • 18.9. Fluke Corporation
  • 18.10. Fuji Electric Co., Ltd.
  • 18.11. Fujifilm Holdings Corporation
  • 18.12. GE HealthCare Technologies, Inc.
  • 18.13. Guerbet
  • 18.14. IBA Dosimetry GmbH
  • 18.15. Infab Corporation
  • 18.16. INFINITT Healthcare Co., Ltd.
  • 18.17. Ion Beam Applications S.A.
  • 18.18. Koninklijke Philips N.V.
  • 18.19. Landauer, Inc.
  • 18.20. LANDAUER, Inc. by Fortive Corporation
  • 18.21. Medic Vision
  • 18.22. Medsquare
  • 18.23. Mirion Technologies, Inc.
  • 18.24. Novarad Corporation
  • 18.25. PACSHealth, LLC
  • 18.26. PTW-Freiburg GmbH
  • 18.27. QAELUM NV
  • 18.28. Radcal Corporation
  • 18.29. Radiation Monitoring Devices, Inc.
  • 18.30. RADOS Technology Oy
  • 18.31. RaySafe by Fluke Corporation
  • 18.32. Sectra AB
  • 18.33. Siemens Healthineers AG
  • 18.34. Thermo Fisher Scientific, Inc.
  • 18.35. Unfors RaySafe AB
  • 18.36. Victoreen, LLC
  • 18.37. Volpara Health Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DOSE MONITORING DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DOSE MONITORING DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES DOSE MONITORING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA DOSE MONITORING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY NON WEARABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY NON WEARABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY NON WEARABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY WEARABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY WEARABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY WEARABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY BLUETOOTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY BLUETOOTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY BLUETOOTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY IOT BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY IOT BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY IOT BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY NFC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY NFC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY NFC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY RFID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY RFID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY RFID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY CARDIOVASCULAR CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY CARDIOVASCULAR CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY CARDIOVASCULAR CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY ONCOLOGY TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY ONCOLOGY TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY ONCOLOGY TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY E COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY E COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY MANUFACTURER WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY MANUFACTURER WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS DOSE MONITORING DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE DOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST DOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC DOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN DOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 137. GCC DOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GCC DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. GCC DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. GCC DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. GCC DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. GCC DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. GCC DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 144. GCC DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION DOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS DOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 161. G7 DOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. G7 DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. G7 DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. G7 DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. G7 DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. G7 DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. G7 DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 168. G7 DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 169. NATO DOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. NATO DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. NATO DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. NATO DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. NATO DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. NATO DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. NATO DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 176. NATO DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL DOSE MONITORING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES DOSE MONITORING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA DOSE MONITORING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA DOSE MONITORING DEVICE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA DOSE MONITORING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA DOSE MONITORING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA DOSE MONITORING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA DOSE MONITORING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA DOSE MONITORING DEVICE MARKET SIZE, BY OFFLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA DOSE MONITORING DEVICE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)